Co-Target(s) Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T83875 | Target Info | |||
Target Name | Monoamine oxidase type A (MAO-A) | ||||
Synonyms |
Monoamine oxidase A; Amine oxidase [flavin-containing] A
Click to Show/Hide
|
||||
Target Type | Successful Target | ||||
Gene Name | MAOA | ||||
Biochemical Class | CH-NH(2) donor oxidoreductase | ||||
UniProt ID |
Co-Targets of This Target | Top | |||||
---|---|---|---|---|---|---|
Co-Target Name | 5-HT 2A receptor (HTR2A) | Successful Target | ||||
UniProt ID | 5HT2A_HUMAN | |||||
Gene Name | HTR2A | |||||
Synonyms |
Serotonin receptor 2A; HTR2; 5-hydroxytryptamine receptor 2A; 5-HT-2A; 5-HT-2
Click to Show/Hide
|
|||||
Representative Drug(s) | TRYPTAMINE | Drug Info | EC50 = 7.36 nM | [1] | ||
Co-Target Name | Monoamine oxidase type B (MAO-B) | Successful Target | ||||
UniProt ID | AOFB_HUMAN | |||||
Gene Name | MAOB | |||||
Synonyms |
MAO-B; Amine oxidase [flavin-containing] B
Click to Show/Hide
|
|||||
Representative Drug(s) | Tranylcypromine | Drug Info | IC50 = 9.4 nM | Click to Show More | [2] | |
2 | PIPERINE | Drug Info | IC50 = 483 nM | [6] | ||
3 | Clorgyline | Drug Info | IC50 ~ 1000 nM | [8] | ||
Co-Target Name | 5-HT 1D receptor (HTR1D) | Successful Target | ||||
UniProt ID | 5HT1D_HUMAN | |||||
Gene Name | HTR1D | |||||
Synonyms |
Serotonin receptor 1D; Serotonin 1D alpha receptor; HTRL; HTR1DA; 5HT1D; 5-hydroxytryptamine receptor 1D; 5-HT1D receptor; 5-HT1D; 5-HT-1D-alpha; 5-HT-1D
Click to Show/Hide
|
|||||
Representative Drug(s) | TRYPTAMINE | Drug Info | Ki = 23 nM | [3] | ||
Co-Target Name | 5-HT 1B receptor (HTR1B) | Successful Target | ||||
UniProt ID | 5HT1B_HUMAN | |||||
Gene Name | HTR1B | |||||
Synonyms |
Serotonin receptor 1B; Serotonin 1D beta receptor; S12; HTR1DB; 5-hydroxytryptamine receptor 1B; 5-HT1B receptor; 5-HT1B; 5-HT-1D-beta; 5-HT-1B
Click to Show/Hide
|
|||||
Representative Drug(s) | TRYPTAMINE | Drug Info | Ki = 36 nM | [3] | ||
Co-Target Name | 5-HT 2C receptor (HTR2C) | Successful Target | ||||
UniProt ID | 5HT2C_HUMAN | |||||
Gene Name | HTR2C | |||||
Synonyms |
Serotonin receptor 2C; HTR1C; 5HT-1C; 5-hydroxytryptamine receptor 2C; 5-hydroxytryptamine receptor 1C; 5-HTR2C; 5-HT2C receptor; 5-HT2C; 5-HT1C; 5-HT-2C; 5-HT-1C
Click to Show/Hide
|
|||||
Representative Drug(s) | TRYPTAMINE | Drug Info | Ki = 50 nM | [4] | ||
Co-Target Name | Opioid receptor sigma 1 (OPRS1) | Successful Target | ||||
UniProt ID | SGMR1_HUMAN | |||||
Gene Name | SIGMAR1 | |||||
Synonyms |
hSigmaR1; Sigma1R; Sigma1-receptor; Sigma non-opioid intracellular receptor 1; Sigma 1-type opioid receptor; SRBP; SR31747-binding protein; SR31747 binding protein 1; SR-BP; SIG-1R; Opioid receptor, sigma 1, isoform 1; OPRS1 protein; Aging-associated gene 8 protein; AAG8
Click to Show/Hide
|
|||||
Representative Drug(s) | Moclobemide | Drug Info | Ki ~ 100 nM | [5] | ||
Co-Target Name | Cytochrome P450 2A6 (CYP2A6) | Successful Target | ||||
UniProt ID | CP2A6_HUMAN | |||||
Gene Name | CYP2A6 | |||||
Synonyms |
Cytochrome P450(I); Cytochrome P450 IIA3; Coumarin 7-hydroxylase; CYPIIA6; CYP2A6; CYP2A3
Click to Show/Hide
|
|||||
Representative Drug(s) | Psoralen | Drug Info | Ki = 600 nM | [7] | ||
Co-Target Name | 5-HT 6 receptor (HTR6) | Clinical trial Target | ||||
UniProt ID | 5HT6R_HUMAN | |||||
Gene Name | HTR6 | |||||
Synonyms |
Serotonin receptor 6; 5-hydroxytryptamine receptor 6; 5-HT6 receptor; 5-HT6; 5-HT-6
Click to Show/Hide
|
|||||
Representative Drug(s) | TRYPTAMINE | Drug Info | Ki = 70 nM | [9] | ||
Co-Target Name | 5-HT 7 receptor (HTR7) | Clinical trial Target | ||||
UniProt ID | 5HT7R_HUMAN | |||||
Gene Name | HTR7 | |||||
Synonyms |
Serotonin receptor 7; 5HT7; 5-hydroxytryptamine receptor 7; 5-HT7 receptor; 5-HT7; 5-HT-X; 5-HT-7
Click to Show/Hide
|
|||||
Representative Drug(s) | TRYPTAMINE | Drug Info | Ki = 158.49 nM | [10] | ||
Co-Target Name | Sigma intracellular receptor 2 (TMEM97) | Clinical trial Target | ||||
UniProt ID | SGMR2_HUMAN | |||||
Gene Name | TMEM97 | |||||
Synonyms |
Transmembrane protein 97; Sigma2 receptor; Sigma-2 receptor; Meningioma-associated protein 30; MAC30
Click to Show/Hide
|
|||||
Representative Drug(s) | Moclobemide | Drug Info | Ki ~ 200 nM | [5] | ||
Co-Target Name | Myeloperoxidase (MPO) | Clinical trial Target | ||||
UniProt ID | PERM_HUMAN | |||||
Gene Name | MPO | |||||
Synonyms |
MPO
Click to Show/Hide
|
|||||
Representative Drug(s) | TRYPTAMINE | Drug Info | IC50 = 770 nM | [11] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Alpha-ethyltryptamines as dual dopamine-serotonin releasers. Bioorg Med Chem Lett. 2014 Oct 1;24(19):4754-8. | ||||
REF 2 | Identification of selective and reversible LSD1 inhibitors with anti-metastasis activity by high-throughput docking. Bioorg Med Chem Lett. 2019 Feb 15;29(4):544-548. | ||||
REF 3 | Binding of O-alkyl derivatives of serotonin at human 5-HT1D beta receptors. J Med Chem. 1996 Jan 5;39(1):314-22. | ||||
REF 4 | Central serotonin receptors as targets for drug research. J Med Chem. 1987 Jan;30(1):1-12. | ||||
REF 5 | Synthesis and pharmacological evaluation of benzamide derivatives as potent and selective sigma-1 protein ligands. Eur J Med Chem. 2017 Sep 29;138:964-78. | ||||
REF 6 | Inhibition of monoamine oxidase by derivatives of piperine, an alkaloid from the pepper plant Piper nigrum, for possible use in Parkinson's disease. Bioorg Med Chem Lett. 2012 Dec 1;22(23):7183-8. | ||||
REF 7 | Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity. Curr Drug Metab. 2005 Oct;6(5):413-54. | ||||
REF 8 | Synthesis of a series of unsaturated ketone derivatives as selective and reversible monoamine oxidase inhibitors. Bioorg Med Chem. 2015 Oct 1;23(19):6486-96. | ||||
REF 9 | 5-ZATRYPTAMINE ANALOGS AS h5-HT6 SEROTONIN RECEPTOR LIGANDS. Med Chem Res. 2005;4:1-18. | ||||
REF 10 | Structure-activity relationships of serotonin 5-HT 7 receptors ligands: A review. Eur J Med Chem. 2019 Dec 1;183:111705. | ||||
REF 11 | Design, synthesis, and structure-activity relationship studies of novel 3-alkylindole derivatives as selective and highly potent myeloperoxidase inhibitors. J Med Chem. 2013 May 23;56(10):3943-58. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.